Cargando…
Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort
BACKGROUND: Hippocampal sclerosis (HS) is a neuropathological finding that frequently occurs with pathologies, such as Alzheimer's disease (AD). Prevalence estimates of HS in autopsy-confirmed dementia samples have varied between 0.4% and 24.5%. However, the prevalence of HS within other pathol...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196704/ https://www.ncbi.nlm.nih.gov/pubmed/25324686 |
_version_ | 1782339514939736064 |
---|---|
author | Malek-Ahmadi, Michael Kahlon, Vickram Adler, Charles H. Obradov, Aleksandra Thind, Kabir Shill, Holly A. Sue, Lucia I. Caviness, John N. Jacobson, Sandra Sabbagh, Marwan N. |
author_facet | Malek-Ahmadi, Michael Kahlon, Vickram Adler, Charles H. Obradov, Aleksandra Thind, Kabir Shill, Holly A. Sue, Lucia I. Caviness, John N. Jacobson, Sandra Sabbagh, Marwan N. |
author_sort | Malek-Ahmadi, Michael |
collection | PubMed |
description | BACKGROUND: Hippocampal sclerosis (HS) is a neuropathological finding that frequently occurs with pathologies, such as Alzheimer's disease (AD). Prevalence estimates of HS in autopsy-confirmed dementia samples have varied between 0.4% and 24.5%. However, the prevalence of HS within other pathologic groups has not been well characterized. METHODS: Utilizing a sample of 910 prospectively followed and clinicopathologically confirmed dementia cases, we determined the prevalence of HS among the sample and within specific pathologic groups. HS prevalence of the sample was compared to reported HS prevalence rates in other autopsy-confirmed dementia samples. RESULTS: The age range of the sample was 43 to 106 years, with a mean of 81.49±8.45. Of the 910 cases, 505 were male and 405 were female. For the entire sample, the average educational level was 14.59±2.65years. Of the 910 individuals, 47 (5.16%) cases had HS pathology present at autopsy. Among the 561 AD cases, 26 (4.43%) had HS pathology present. The frontotemporal dementia (FTD)/Pick's group had the highest percentage of cases with HS pathology (23.08%) followed by primary progressive aphasia (PPA) (16.67%) and Parkinson's disease with dementia (PDD) (5.34%). The HS prevalence rate of this study was not significantly different from all but 2 studies. CONCLUSION: The prevalence of HS pathology in this sample of autopsy-confirmed dementia cases was similar to other reported HS prevalence rates. This study is the first to report the presence of HS pathology in PDD cases. |
format | Online Article Text |
id | pubmed-4196704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-41967042014-10-14 Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort Malek-Ahmadi, Michael Kahlon, Vickram Adler, Charles H. Obradov, Aleksandra Thind, Kabir Shill, Holly A. Sue, Lucia I. Caviness, John N. Jacobson, Sandra Sabbagh, Marwan N. Clin Exp Med Sci Article BACKGROUND: Hippocampal sclerosis (HS) is a neuropathological finding that frequently occurs with pathologies, such as Alzheimer's disease (AD). Prevalence estimates of HS in autopsy-confirmed dementia samples have varied between 0.4% and 24.5%. However, the prevalence of HS within other pathologic groups has not been well characterized. METHODS: Utilizing a sample of 910 prospectively followed and clinicopathologically confirmed dementia cases, we determined the prevalence of HS among the sample and within specific pathologic groups. HS prevalence of the sample was compared to reported HS prevalence rates in other autopsy-confirmed dementia samples. RESULTS: The age range of the sample was 43 to 106 years, with a mean of 81.49±8.45. Of the 910 cases, 505 were male and 405 were female. For the entire sample, the average educational level was 14.59±2.65years. Of the 910 individuals, 47 (5.16%) cases had HS pathology present at autopsy. Among the 561 AD cases, 26 (4.43%) had HS pathology present. The frontotemporal dementia (FTD)/Pick's group had the highest percentage of cases with HS pathology (23.08%) followed by primary progressive aphasia (PPA) (16.67%) and Parkinson's disease with dementia (PDD) (5.34%). The HS prevalence rate of this study was not significantly different from all but 2 studies. CONCLUSION: The prevalence of HS pathology in this sample of autopsy-confirmed dementia cases was similar to other reported HS prevalence rates. This study is the first to report the presence of HS pathology in PDD cases. 2013 /pmc/articles/PMC4196704/ /pubmed/25324686 Text en Copyright © 2013 Michael Malek-Ahmadi et al. http://creativecommons.org/licenses/by/2.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Malek-Ahmadi, Michael Kahlon, Vickram Adler, Charles H. Obradov, Aleksandra Thind, Kabir Shill, Holly A. Sue, Lucia I. Caviness, John N. Jacobson, Sandra Sabbagh, Marwan N. Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort |
title | Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort |
title_full | Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort |
title_fullStr | Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort |
title_full_unstemmed | Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort |
title_short | Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort |
title_sort | prevalence of hippocampal sclerosis in a clinicopathologically characterized cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196704/ https://www.ncbi.nlm.nih.gov/pubmed/25324686 |
work_keys_str_mv | AT malekahmadimichael prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT kahlonvickram prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT adlercharlesh prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT obradovaleksandra prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT thindkabir prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT shillhollya prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT sueluciai prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT cavinessjohnn prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT jacobsonsandra prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort AT sabbaghmarwann prevalenceofhippocampalsclerosisinaclinicopathologicallycharacterizedcohort |